patient diagnostic News
-
Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2018
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2018, at 2:15 p.m. (ET) at the Grand Hyatt New York, New York. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving ...
-
Thermo Fisher Scientific to present at the BofA Securities 2021 Healthcare Conference on May 12, 2021
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the BofA Securities 2021 Health Care Conference on Wednesday, May 12, 2021 at 8:45 a.m. (EDT). You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com. About ...
-
Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 9:40 a.m. (EDT). You can access the webcast of the presentation via the Investors section of our website About Thermo ...
-
Thermo Fisher Scientific to Present at BofA Securities 2020 Health Care Conference
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will participate in a virtual fireside chat at the BofA Securities 2020 Health Care Conference on Wednesday, May 13, 2020, at 8:20 a.m. (EST). About Thermo Fisher Scientific Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader ...
-
Thermo Fisher Scientific to Present at 41st Annual Cowen Healthcare Conference on March 3, 2021
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 41st Annual Cowen Healthcare Conference on Wednesday, March 3, 2021, at 10:20 a.m. (EDT). You can access the webcast of the presentation via the Investors section of our website. About Thermo Fisher ...
-
Thermo Fisher Scientific to Present at 38th Annual J.P. Morgan Healthcare Conference on January 13, 2020
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Monday, January 13, 2020, at 4:00 p.m. (PST) followed by a Q&A session at 4:30 p.m. (PST). You can access the webcast of the presentation and ...
-
Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 15, 2020
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2020, at 8:00 a.m. (ET). You can access the live webcast of the presentation via the Investors section of our website, ...
-
Thermo Fisher Scientific to Present at the Evercore ISI HealthCONx Conference on December 1, 2020
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Evercore ISI HealthCONx Conference on Tuesday, December 1, 2020, at 1:00 p.m. (EST). Among other topics, Mr. Casper will provide the company's current perspective on the impact of the COVID-19 pandemic and ...
-
Thermo Fisher Scientific to Present at 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021, at 3:40 p.m. (EDT). Among other topics, Mr. Casper will provide the company's current perspective on the impact of the COVID-19 ...
-
Thermo Fisher Scientific Offers Financial Flexibility with New Managed Equipment Solutions
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of Managed Equipment Solutions, a new subscription-based offering that bundles instrument and equipment procurement with consumables, applications support, software, training and extended service in a convenient and cost-efficient agreement. Managed Equipment Solutions (MES) is ideal for ...
-
Thermo Fisher Scientific Announces Collaboration with Ortho Clinical Diagnostics
Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Ortho Clinical Diagnostics to promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for use with Ortho Clinical Diagnostics VITROS analyzers. Through this agreement, Ortho Clinical Diagnostics customers will have complete access to MAS third-party ...
-
Thermo Fisher Scientific Launches Customizable TaqMan SARS-CoV-2 Mutation Panel
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel, a customizable menu of 22 verified real-time PCR assays for identification of SARS-CoV-2 mutations. These assays enable surveillance of variants that are causing COVID-19 infections in specific regions globally and allow laboratories to choose which ...
-
Thermo Fisher Scientific Further Expands Global Footprint for Drug Product Development and Commercial Manufacturing
Thermo Fisher Scientific, the world leader in serving science, today announced it will further expand its footprint in North America and Europe for sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines. "We have continued to invest strategically in capacity, technology and expertise across our global network so we can accelerate innovation ...
-
Thermo Fisher Scientific Opens Customer Solution Center in China to Support Pharmaceutical and Biopharmaceutical Laboratories
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of a Customer Solution Center in Shanghai, China. This follows the recent announcements of a Biosciences Customer Exploration Center in Shanghai and the expansion of our clinical trials logistics facility in Suzhou. The new Pharma and BioPharma Center will support the rapid delivery of novel ...
-
Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex
Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research. Phitonex's product offering will enable ...
-
Thermo Fisher Scientific Announces Plans to Expand Sterile Filling Capacity for Therapies and Vaccines with New Facility in Singapore
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to develop two new sterile filling lines in Singapore to extend capacity to the Asia-Pacific region for the development and manufacture of therapies and vaccines. Established with the support of the Singapore Economic Development Board (EDB), the US$130M facility will be operated by Thermo ...
-
Thermo Fisher Scientific`s Support of COVID-19 Response Continues to Expand with U.S. Government Contract for Products Used in Sample Collection
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has received a contract from the U.S. government to provide highly specialized viral transport media (VTM) for COVID-19 sample collection. The VTM is used during collection of patient samples for proper transport to laboratories that can test for the presence of the virus. To ensure accuracy of ...
-
Thermo Fisher Scientific to Double its Capacity of Viral Vector Manufacturing
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it is expanding capacity for viral vector development and manufacturing services with construction of a new commercial manufacturing site in Plainville, Mass. The $180 million project will more than double the company's commercial viral vector capacity to support increasing demand for the development ...
-
Thermo Fisher Scientific Unveils $6 Million Expansion at Viral Vector Manufacturing Facility
Thermo Fisher Scientific, the world leader in serving science, today unveiled the $6 million expansion of its gene therapy and viral vector services site in Alachua, Florida. The investment doubles the site’s laboratory and warehousing capacity for upstream process development and quality control testing of gene therapy products. The expansion at the Alachua facility is part of Thermo ...
-
Thermo Fisher Scientific to Present at the 2022 Goldman Healthcare CEOs Unscripted Conference
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 2022 Goldman Healthcare CEOs Unscripted Conference on Thursday, January 6, 2022, at 9:00 a.m. (EDT). You can access the webcast of the presentation via the Investors section of our website. About Thermo ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you